Visolis provides biomanufacturing solutions by combining synthetic biology and chemical catalysis to produce bio-based chemicals and fuels.
Visolis has raised $2.9M in total funding. The most recent round was Grant. The last funding was announced in January 2026.
Visolis's investors include Global Brain Corporation, Acequia Capital (AceCap), National Science Foundation, Cantos, Creative Ventures.
Visolis is headquartered in Hayward, United States.
Visolis provides biomanufacturing solutions by combining synthetic biology and chemical catalysis to produce bio-based chemicals and fuels.
Visolis is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Visolis — Funding & Investors." VCBacked, January 29, 2026, https://www.vcbacked.co/company/visolis. Accessed August 14, 2026.
VCBacked. (2026). Visolis — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/visolis
{{cite web |title=Visolis — Funding & Investors |url=https://www.vcbacked.co/company/visolis |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated